Medical specialists from France tagged as investigators in clinical trials studying Purpura

Total 34 results

Albert Faye, MD PhD
Seen in:
- Paris, Robert Debre Hospital
Trials:
- NCT04685850 (Principal Investigator)
Conditions:
- Meningitis, Meningococcal;
- Sequela
Arnaud BOUTET, MD
Seen in:
- Saint Nazaire, Hosptal of Saint Nazaire
Trials:
- NCT00331357 (Principal Investigator)
Conditions:
- Acute Idiopathic Thrombocytopenic Purpura
Bruno ROYER, MD
Seen in:
- Amiens, CHU Amiens
Trials:
- NCT01648556 (Sub-Investigator)
Conditions:
- Purpura Thrombopenic
Caroline Thomas, MD
Seen in:
- Nantes, UH of Nantes
Trials:
- NCT00331357 (Principal Investigator)
Conditions:
- Acute Idiopathic Thrombocytopenic Purpura
Catherine RADET, MD
Seen in:
- Cholet, Hospital of Cholet
Trials:
- NCT00331357 (Sub-Investigator)
Conditions:
- Acute Idiopathic Thrombocytopenic Purpura
Claire Berger
Seen in:
- Loire, Saint-Priest-en-Jarez cedex, CHU Saint Etienne - Hôpital Nord
- Saint-Étienne, CHU Saint-Etienne
Trials:
- NCT04683003 (Principal Investigator)
- NCT02866526 (Principal Investigator)
- NCT03393975 (Principal Investigator)
Conditions:
- Thrombotic Thrombocytopenic Purpura (TTP);
- Haemophilia
Claire Dossier
Seen in:
- Paris, Hôpital Robert Debré - Paris
- Paris, Hôpital Robert Debré- Paris
Trials:
- NCT04683003 (Principal Investigator)
- NCT03393975 (Principal Investigator)
Conditions:
- Thrombotic Thrombocytopenic Purpura (TTP)
Dominique MEDINGER, MD
Seen in:
- La Roche Sur Yon, Hospital of La Roche Sur Yon
Trials:
- NCT00331357 (Sub-Investigator)
Conditions:
- Acute Idiopathic Thrombocytopenic Purpura
Elaine TARRAL, MD
Seen in:
- Le Mans, Hospital of Le Mans
Trials:
- NCT00331357 (Principal Investigator)
Conditions:
- Acute Idiopathic Thrombocytopenic Purpura
Eric PARIS, MD
Seen in:
- Laval, Hospital of Laval
Trials:
- NCT00331357 (Sub-Investigator)
Conditions:
- Acute Idiopathic Thrombocytopenic Purpura
Estelle DARVIOT, MD
Seen in:
- Angers, UH of Angers
Trials:
- NCT00331357 (Sub-Investigator)
Conditions:
- Acute Idiopathic Thrombocytopenic Purpura
Evangeline Pillebout, MDPhD
Seen in:
- Paris, Nephrology Unit - Hôpital St Louis
Trials:
- NCT01610830 (Principal Investigator)
Conditions:
- Purpura, Schoenlein-Henoch
Francis CHOMIENNE, MD
Seen in:
- Cholet, Hospital of Cholet
Trials:
- NCT00331357 (Sub-Investigator)
Conditions:
- Acute Idiopathic Thrombocytopenic Purpura
Francois Provot
Seen in:
- Lille, Hopital Claude Huriez - CHU Lille
- Nord, Lille, Hopital Claude Huriez - CHU Lille
Trials:
- NCT04683003 (Principal Investigator)
- NCT03393975 (Principal Investigator)
Conditions:
- Thrombotic Thrombocytopenic Purpura (TTP)
Françoise MECHINAUD, MD
Seen in:
- Nantes, UH of Nantes
Trials:
- NCT00331357 (Sub-Investigator)
Conditions:
- Acute Idiopathic Thrombocytopenic Purpura
Guy SEGUIN, MD
Seen in:
- Cholet, Hospital of Cholet
Trials:
- NCT00331357 (Principal Investigator)
Conditions:
- Acute Idiopathic Thrombocytopenic Purpura
Isabelle GRIMAL, MD
Seen in:
- Cholet, Hospital of Cholet
Trials:
- NCT00331357 (Sub-Investigator)
Conditions:
- Acute Idiopathic Thrombocytopenic Purpura
Isabelle Pellier, Pr
Seen in:
- Angers, CHU d'Angers
Trials:
- NCT03123497 (Principal Investigator)
Conditions:
- Idiopathic Thrombocytopenic Purpura
Jean-Pierre MAROLLEAU, MD-PhD
Seen in:
- Amiens, CHU Amiens
Trials:
- NCT01648556 (Principal Investigator)
Conditions:
- Purpura Thrombopenic
Joachim BASSIL, MD
Seen in:
- Laval, Hospital of Laval
Trials:
- NCT00331357 (Principal Investigator)
Conditions:
- Acute Idiopathic Thrombocytopenic Purpura
Krimo BOUABDALLAH
Seen in:
- Pessac, Service des maladies du sang - Hôpital Haut-Lévêque - avenue de magellan
Trials:
- NCT04003220 (Sub-Investigator)
Conditions:
Lionel GALICIER, MD
Seen in:
- Paris, Immunopathologie Clinique - Hôpital Saint Louis - AP HP
Trials:
- NCT04003220 (Principal Investigator)
Conditions:
Marie-Chantal CHEVALLIER, MD
Seen in:
- Le Mans, Hospital of Le Mans
Trials:
- NCT00331357 (Sub-Investigator)
Conditions:
- Acute Idiopathic Thrombocytopenic Purpura
Marie-Sarah DILHUYDY
Seen in:
- Pessac, Service des maladies du sang - Hôpital Haut-Lévêque - avenue de magellan
Trials:
- NCT04003220 (Sub-Investigator)
Conditions:
Mathieu PERNOT, MD
Seen in:
- Pessac, Chirurgie cardiaque - Hôpital Haut Lévêque - CHU de Bordeaux
Trials:
- NCT04003220 (Principal Investigator)
Conditions:
Mehdi KHELLAF, MD
Seen in:
- Val de Marne, Creteil, Henri Mondor University Hospital
Trials:
- NCT01101295 (Sub-Investigator)
Conditions:
- Purpura, Thrombocytopenic, Idiopathic;
- Autoimmune Thrombocytopenia
Nathalie Biebuyck
Seen in:
- Paris, Paris cedex 15, Hôpital Necker - Enfants Malades
Trials:
- NCT04683003 (Principal Investigator)
- NCT03393975 (Principal Investigator)
Conditions:
- Thrombotic Thrombocytopenic Purpura (TTP)
Nathalie GUILLEY, MD
Seen in:
- La Roche Sur Yon, Hospital of La Roche Sur Yon
Trials:
- NCT00331357 (Principal Investigator)
Conditions:
- Acute Idiopathic Thrombocytopenic Purpura
Noel MILPIED
Seen in:
- Pessac, Service des maladies du sang - Hôpital Haut-Lévêque - avenue de magellan
Trials:
- NCT04003220 (Principal Investigator)
Conditions:
Paul Coppo
Seen in:
- Paris, Hopital Saint-Antoine
- Paris, Paris cedex 12, Hopital Saint-Antoine
Trials:
- NCT04683003 (Principal Investigator)
- NCT03393975 (Principal Investigator)
Conditions:
- Thrombotic Thrombocytopenic Purpura (TTP)

Clinical Trials on Purpura

Turkish Hematology Association
Sanofi

Recruiting

Turkey Thrombotic Thrombocytopenic Purpura Disease Registry: National Multicenter Study

TTP - Thrombotic Thrombocytopenic Purpura

Turkey
University of Cologne

Recruiting

Platelet Response to Caplacizumab in the Treatment of Acquired Thrombotic Thrombocytopenic Purpura (PREDICT2020)

Acquired Thrombotic Thrombocytopenic Purpura

Germany
Peking Union Medical College Hospital

Not yet recruiting

Efficacy and Safety of Bortezomib as First-line Treatment of Acquired TTP

Thrombotic Thrombocytopenic Purpura, Acquired

China
Fundación Española de Hematología y Hemoterapía

Recruiting

Improvement of Immunologic and Molecular Techniques for the Diagnosis and Follow-up of Patients With Thrombotic Thrombocytopenic Purpura

Acquired Thrombotic Thrombocytopenic Purpura

Spain, Portugal
University of Cologne

Recruiting

Retrospective Analysis of the Efficiency of Caplacizumab in the Treatment of aTTP (REACT-2020)

Acquired Thrombotic Thrombocytopenic Purpura

Germany
Takeda

Available

Expanded Access Program of TAK-755 for Congenital Thrombotic Thrombocytopenic Purpura (cTTP)

Thrombotic Thrombocytopenic Purpura (TTP)
Ablynx, a Sanofi company

Completed

Study to Assess Efficacy and Safety of Anti-von Willebrand Factor (vWF) Nanobody in Patients With Acquired Thrombotic Thrombocytopenic Purpura (aTTP) (TITAN)

Acquired Thrombotic Thrombocytopenic Purpura

United States, Austria, Belgium, France, Germany, Israel, Italy, Spain, Switzerland, United Kingdom, Bulgaria, Romania, Australia
Sanofi

Completed

A Trial of Caplacizumab in Japanese Patients With Acquired Thrombotic Thrombocytopenic Purpura (aTTP)

Thrombotic Thrombocytopenic Purpura

Japan
Sanofi

Completed

Follow-up Study for Patients Who Completed Study ALX0681-C301 (Post-HERCULES)

Acquired Thrombotic Thrombocytopenic Purpura

United States, Austria, Belgium, Canada, Czechia, France, Hungary, Israel, Italy, Spain, Switzerland, Turkey, United Kingdom
Takeda
Shire; Takeda Development Center Americas, Inc.

Recruiting

A Study of TAK-755 in Participants With Congenital Thrombotic Thrombocytopenic Purpura

Thrombotic Thrombocytopenic Purpura (TTP)

China, United States, France, Japan, Poland, Germany, Austria, Spain, Italy, Switzerland, United Kingdom

Medical specialists from France tagged as investigators in clinical trials studying Purpura

Clinical Trials on Purpura

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Colombia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations